Investors

Copyright Nasdaq. Minimum 15 minutes delayed.

A Clear Path Ahead

IMV Inc. (Nasdaq: IMV) (TSX: IMV) has the potential to fundamentally transform the way we use our immune system to address a broad range of serious diseases. We continue to build value in our Company by establishing collaborations with leading biotechnology and pharmaceutical companies; advancing our clinical programs; and seeking additional opportunities to leverage our novel formulation technology in underserved markets.

News Releases